consolidated financial statements fiscal year ended december otsuka holdings co ltd financial information basis preparation consolidated financial statements consolidated financial statements otsuka holdings co ltd hereinafter referred company prepared accordance international financial reporting standards hereinafter referred ifrs pursuant provision article ordinance terminology forms preparation methods consolidated financial statements ordinance ministry finance hereinafter referred ordinance consolidated financial statements audit certification accordance provision article paragraph financial instruments exchange act consolidated financial statements fiscal year ended december audited kpmg azsa llc special effort ensure appropriateness consolidated financial statements others development system preparing consolidated financial statements appropriately accordance ifrs company making special effort ensure appropriateness consolidated financial statements others developing system preparing consolidated financial statements others appropriately accordance ifrs details follows order develop system ensures proper understanding contents accounting standards etc adequate response changes accounting standards others company joined financial accounting standards foundation regularly provides internal training subscribes professional journals published japanese institute certified public accountants attends seminars hosted financial accounting standards foundation auditing firms etc makes efforts regard application ifrs company keeps accounting standards obtaining press releases standards published international accounting standards board addition company developed groups accounting policies accounting guidelines accordance ifrs practices accounting procedures based policies guidelines prepare appropriate consolidated financial statements accordance ifrs consolidated financial statements consolidated financial statements consolidated statements financial position millions yen fy fy note december december assets current assets cash cash equivalents trade receivables inventories income taxes receivable financial assets current assets subtotal assets held sale total current assets noncurrent assets property plant equipment goodwill intangible assets investments accounted using equity method financial assets deferred tax assets noncurrent assets total noncurrent assets total assets millions yen fy fy note december december liabilities equity liabilities current liabilities trade payables bonds borrowings lease liabilities financial liabilities income taxes payable provisions contract liabilities current liabilities subtotal liabilities directly associated assets held sale total current liabilities noncurrent liabilities bonds borrowings lease liabilities financial liabilities net defined benefit liabilities provisions contract liabilities deferred tax liabilities noncurrent liabilities total noncurrent liabilities total liabilities equity equity attributable owners company share capital capital surplus treasury shares retained earnings components equity total equity attributable owners company noncontrolling interests total equity total liabilities equity ii consolidated statements income millions yen fy fy note fiscal year ended fiscal year ended december december revenue cost sales gross profit selling general administrative expenses share profit investments accounted using equity method research development expenses impairment losses income expenses operating profit finance income finance expenses profit tax income tax expenses profit year attributable owners company noncontrolling interests earnings per share basic earnings per share yen diluted earnings per share yen iii consolidated statements comprehensive income millions yen fy fy note fiscal year ended fiscal year ended december december profit year comprehensive income items reclassified profit loss remeasurements defined benefit plans financial assets measured fair value comprehensive income share comprehensive income investments accounted using equity method subtotal items may reclassified profit loss exchange differences translation foreign operations cash flow hedges share comprehensive income investments accounted using equity method subtotal total comprehensive income comprehensive income year attributable owners company noncontrolling interests comprehensive income year iv consolidated statements changes equity fy fiscal year ended december millions yen equity attributable owners company components equity financial assets remeasure measured capital treasury retained ments fair value note share capital surplus shares earnings defined benefit plans comprehen sive income balance january profit year comprehensive income comprehensive income year purchase treasury shares dividends sharebased payment transactions changes ownership interests subsidiaries result loss control transfer components equity retained earnings decrease consolidated subsidiaries noncontrolling interests total transactions owners balance december equity attributable owners company components equity exchange differences non cash flow note total total controlling total equity translation hedges interests foreign operations balance january profit year comprehensive income comprehensive income year purchase treasury shares dividends sharebased payment transactions changes ownership interests subsidiaries result loss control transfer components equity retained earnings decrease consolidated subsidiaries noncontrolling interests total transactions owners balance december fy fiscal year ended december millions yen equity attributable owners company components equity financial assets remeasure measured capital treasury retained ments fair value note share capital surplus shares earnings defined benefit plans comprehen sive income balance january profit year comprehensive income comprehensive income year purchase treasury shares dividends sharebased payment transactions changes ownership interests subsidiaries result loss control changes associated losing control subsidiaries transfer components equity retained earnings total transactions owners balance december equity attributable owners company components equity exchange differences non cash flow note total total controlling total equity translation hedges interests foreign operations balance january profit year comprehensive income comprehensive income year purchase treasury shares dividends sharebased payment transactions changes ownership interests subsidiaries result loss control changes associated losing control subsidiaries transfer components equity retained earnings total transactions owners balance december v consolidated statements cash flows millions yen fy fy note fiscal year ended fiscal year ended december december cash flows operating activities profit tax depreciation amortization expenses impairment losses reversal impairment losses share profit investments accounted using equity method finance income finance expenses increase decrease inventories decrease trade receivables increase decrease trade payables others subtotal interest dividends received interest paid income taxes paid net cash flows provided operating activities cash flows investing activities proceeds sales property plant equipment payments acquisition property plant equipment payments acquisition intangible assets proceeds sales redemption investments payments acquisition investments payments acquisition subsidiaries increase decrease time deposits others net cash flows used investing activities cash flows financing activities purchase treasury shares change shortterm borrowings net proceeds longterm borrowings repayments longterm borrowings repayments lease liabilities dividends paid others net cash flows used financing activities increase cash cash equivalents cash cash equivalents beginning year effect exchange rate changes cash cash equivalents cash cash equivalents end year notes consolidated financial statements reporting entity otsuka holdings co ltd hereinafter referred company company incorporated japan addresses registered head office principal business office disclosed companys website url httpswwwotsukacomen consolidated financial statements company prepared end fiscal year december comprise company subsidiaries hereinafter referred group interests associates details businesses principal business activities group provided note operating segments basis preparation compliance ifrs pursuant provision article ordinance consolidated financial statements consolidated financial statements company prepared compliance ifrs since company qualifies specified company designated international accounting standards prescribed article ordinance companys consolidated financial statements fiscal year ended december approved march tatsuo higuchi president representative director ceo yuko makino executive director cfo basis measurement consolidated financial statements prepared historical cost basis except financial instruments items measured fair value functional currency presentation currency consolidated financial statements presented japanese yen companys functional currency figures rounded nearest million yen change presentation disclosure group revised presentation disclosure consolidated financial statements notes consolidated financial statements current fiscal year purpose providing useful information stakeholders due revision comparative information consolidated financial statements notes consolidated financial statements previous fiscal year additionally disclosed disclosure less significant information omitted new standards yet adopted among standards interpretations newly issued amended date approval provided compliance ifrs new amended standards interpretations early adopted group december impact adoption standards interpretations provided expected insignificant significant accounting policies basis consolidation subsidiaries subsidiaries entities controlled group group controls investee group power investee exposed rights variable returns arising groups involvement investee ability affect returns power investee financial statements subsidiaries included consolidated financial statements date group obtains control date control lost accounting policies applied subsidiary differ applied group adjustments made subsidiarys financial statements needed balances receivables payables among group intercompany transactions well unrealized gains losses arising inter company transactions offset preparing consolidated financial statements ownership interest subsidiary partially disposed transaction accounted equity transaction group retains control subsidiary difference amount adjustment noncontrolling interests fair value consideration paid received recognized directly equity attributable owners company group loses control subsidiary gains losses derived loss recognized profit loss ii associates associates entities group significant influence terms financial operating policies group control jointly control group presumed significant influence another entity holds least less voting rights entity investments associates recognized cost time acquisition subsequently accounted using equity method goodwill recognized acquisition included investments associates goodwill separately recognized tested impairment separately instead entire amount investments associates tested impairment single asset whenever objective evidence indicates investments associates may impaired accounting policies applied associate differ applied group adjustments made associates financial statements needed group retained interests losing significant influence interests measured fair value difference fair value carrying amount investment date equity method discontinued recognized profit loss business combinations business combinations accounted using acquisition method goodwill measured excess aggregate consideration transferred amount non controlling interests acquiree acquisitiondate fair value acquirers previously held equity interest acquiree net acquisitiondate amounts identifiable assets acquired liabilities assumed case identifiable net asset exceeds aggregate consideration others excess immediately recognized profit loss consideration transferred calculated sum acquisitiondate fair values assets transferred acquirer liabilities incurred acquirer former owners acquiree equity interests issued acquirer consideration transferred includes assets liabilities resulting contingent consideration arrangement amount noncontrolling interests acquiree acquisition date measured business combination either fair value present ownership instruments proportionate share recognized amounts acquirees identifiable net assets identifiable assets acquired liabilities assumed acquisition date measured fair value acquisition date except limited exceptions based requirements ifrs business combinations transaction costs incurred relation business combinations recognized expenses incurred initial accounting business combinations incomplete end fiscal year business combinations occur group reports provisional amounts items accounting incomplete provisional amounts recognized acquisition date retrospectively adjusted reflect new information obtained measurement period facts circumstances existed acquisition date known acquisition date would affected measurement amounts recognized additional assets liabilities recognized new information known resulted additional recognition assets liabilities measurement period exceed one year foreign currency translation foreign currency transactions foreign currency transactions translated functional currencies exchange rates transaction dates exchange rates close actual rate transaction dates foreign currency monetary assets liabilities translated functional currency exchange rate reporting date nonmonetary assets liabilities measured fair value foreign currency translated functional currency using exchange rate date measurement nonmonetary assets liabilities measured cost foreign currency translated functional currency using spot exchange rate date original transaction translation differences arising translations settlements recognized profit loss however equity instruments measured comprehensive income well effective portion translation differences arising hedging instruments related cash flow hedges used hedge foreign currency risk recognized comprehensive income ii foreign operations assets liabilities foreign operations translated japanese yen exchange rate reporting date revenues expenses foreign operations translated japanese yen average exchange rate reporting period translation differences arising translation financial statements foreign operations recognized comprehensive income exchange differences translation foreign operations recognized profit loss periods foreign operations disposed financial instruments financial assets initial recognition measurement trade receivables initially recognized date incurred financial assets initially recognized contract date group becomes party contract instruments initial recognition financial assets except measured fair value profit loss measured fair value plus directly attributable transaction costs however trade receivables contain significant financing component measured transaction price transaction costs financial assets measured profit loss recognized profit loss initial recognition financial assets classified financial assets measured amortized cost b debt instruments measured fair value comprehensive income c equity instruments measured fair value comprehensive income financial assets measured fair value profit loss financial assets measured amortized cost financial assets classified financial assets measured amortized cost following conditions met financial assets held within business model whose objective hold financial assets order collect contractual cash flows contractual terms financial asset give rise specified dates cash flows solely payments principal interest principal amount outstanding b debt instruments measured fair value comprehensive income financial assets classified debt instruments measured fair value comprehensive income following conditions met financial asset held within business model whose objective achieved collecting contractual cash flows selling financial assets contractual terms financial asset give rise specified dates cash flows solely payments principal interest principal amount outstanding c equity instruments measured fair value comprehensive income investments equity instruments group chosen irrevocable option present subsequent changes fair value investments neither held trading contingent consideration recognized acquirer business combination ifrs business combinations applies comprehensive income group classifies investments equity instruments measured fair value comprehensive income financial assets measured fair value profit loss financial assets except financial assets measured amortized cost equity instruments measured fair value comprehensive income stated classified financial assets measured fair value profit loss ii subsequent measurement initial recognition financial assets measured according classification follows financial assets measured amortized cost financial assets measured amortized cost measured amortized cost using effective interest method amortization using effective interest method gains losses derecognition recognized profit loss b equity instruments measured fair value comprehensive income equity instruments measured fair value comprehensive income measured fair value changes fair value recognized comprehensive income financial assets derecognized accumulated comprehensive income transferred retained earnings meanwhile dividends financial assets recognized profit loss c financial assets measured fair value profit loss financial assets measured fair value profit loss measured fair value changes fair value recognized profit loss iii impairment regard impairment financial assets measured amortized cost group recognizes allowance expected credit losses financial assets reporting date group evaluates whether credit risk financial instruments increased significantly initial recognition credit risk financial instruments increased significantly initial recognition allowance instruments measured amount equal month expected credit losses credit risk financial instruments increased significantly initial recognition allowance financial instruments measured amount equal lifetime expected credit losses group considers significant increase credit risk contractual payments days past due assessment whether credit risk increased significantly takes account relevant current information reasonably available group well past due information however regard trade receivables contain significant financing component allowance always measured amount equal lifetime expected credit losses regardless whether significant increase credit risk initial recognition iv derecognition group derecognizes financial assets contractual rights cash flows financial assets expire group transfers substantially risks rewards ownership financial assets ii financial liabilities initial recognition measurement bonds borrowings initially recognized date issued incurred financial liabilities initially recognized contract date group becomes party contract financial instruments initial recognition financial liabilities classified financial liabilities measured amortized cost b financial liabilities measured fair value profit loss initial recognition financial liabilities measured amortized cost measured fair value net transaction costs directly attributable financial liabilities transaction costs financial liabilities measured fair value profit loss recognized profit loss ii subsequent measurement initial recognition financial liabilities measured according classification follows financial liabilities measured amortized cost financial liabilities measured amortized cost measured amortized cost using effective interest method amortization using effective interest method gains losses derecognition recognized profit loss b financial liabilities measured fair value profit loss financial liabilities measured fair value profit loss measured fair value changes fair value recognized profit loss iii derecognition group derecognizes financial liabilities extinguished obligations specified contract discharged cancelled expired iii offsetting financial assets financial liabilities financial assets financial liabilities offset net amount presented group currently legally enforceable right set recognized amount intends either settle net basis realize assets settle liabilities simultaneously iv derivatives hedge accounting derivatives initially recognized fair value initial recognition derivatives continue measured fair value group designates certain derivatives forward foreign exchange contracts currency swap agreements currency option transactions interest rate swap agreements hedge foreign currency risk interest rate risk inception hedging relationship group formally designates documents hedging relationship risk management objective strategy undertaking hedge documentation includes identification hedging instrument hedged item nature risk hedged methods assessing whether hedging relationship meets hedge effectiveness requirements group assesses whether hedging relationship meets hedge effectiveness requirements inception ongoing basis ongoing assessments performed reporting date upon significant change circumstances affecting hedge effectiveness requirements whichever comes first group applies hedge accounting cash flow hedges meet criteria hedge accounting hedges accounted follows portions gain loss hedging instrument determined effective hedges recognized comprehensive income remaining ineffective portions recognized profit loss amounts associated hedging instruments recognized comprehensive income reclassified profit loss hedged transactions affect profit loss however cases hedged forecast transaction subsequently results recognition nonfinancial asset liability amount recognized comprehensive income accounted adjustment initial carrying amount nonfinancial asset liability hedging relationship ceases meet qualifying criteria hedging instrument expires sold terminated exercised application hedge accounting discontinued prospectively forecast transactions firm commitments longer expected occur related cumulative gains losses recognized equity comprehensive income reclassified profit loss group undertake fair value hedges hedges net investment foreign operations cash cash equivalents cash cash equivalents consist cash hand demand deposits shortterm investments original maturities three months less readily convertible known amounts cash near maturity present insignificant risk changes value inventories inventories measured lower cost net realizable value net realizable value estimated selling price ordinary course business less estimated costs completion estimated costs necessary make sale cost inventories determined mainly weightedaverage cost formula cost inventories comprises costs purchase costs conversion costs incurred bringing inventories present location condition property plant equipment property plant equipment measured cost model carried cost less accumulated depreciation impairment losses cost property plant equipment includes cost directly incidental acquisition assets initial estimated costs dismantling removing restoring assets depreciation expense assets except land construction progress recognized mainly straightline method respective estimated useful lives estimated useful lives major asset items follows buildings structures years machinery vehicles years tools furniture fixtures years estimated useful lives residual values depreciation methods assets reviewed end fiscal year changes applied prospectively change accounting estimate goodwill measurement goodwill initial recognition provided business combinations initial recognition amount recorded cost less accumulated impairment losses goodwill allocated cashgenerating units groups cashgenerating units hereinafter referred cashgenerating units expected benefit synergies business combination cashgenerating units goodwill allocated tested impairment annually whenever indication unit may impaired recoverable amount cashgenerating units less carrying amounts impairment loss recognized profit loss regard allocation impairment losses recognized association cashgenerating units first carrying amount goodwill allocated unit reduced remaining amount impairment loss allocated assets unit pro rata basis carrying amount asset unit impairment losses recognized goodwill reversal made subsequent periods intangible assets intangible assets measured cost model carried cost less accumulated amortization impairment losses separately acquired intangible assets initially measured cost intangible assets acquired business combination measured fair value acquisition date internally generated intangible assets development expenses meet requirements capitalization recognized expense incurred intangible assets finite useful lives amortized straightline method estimated useful lives estimated useful lives major intangible assets follows patents years trademarks distribution rights others years software years estimated useful lives residual values amortization methods reviewed end fiscal year changes applied prospectively change accounting estimate intangible assets indefinite useful lives consist mainly brands trademarks acquired separately business combinations included intangible assets trademarks distribution rights others intangible assets indefinite useful lives reviewed end fiscal year determine whether indefinite useful life assessment remains appropriate longer appropriate change useful life assessment indefinite finite accounted change accounting estimate inprocess research development acquired separately business combination included intangible assets inprocess research development assets intangible assets yet available use tested impairment without amortization asset inprocess research development transferred trademarks distribution rights others asset becomes available use obtaining permits approvals regulatory authorities subsequent period begins amortized straightline method estimated useful life time leases leases group contracted lessee rightofuse assets measured cost lease liabilities measured present value total lease payments rightofuse assets depreciated straightline method estimated useful lives lease terms whichever shorter depreciation periods rightofuse assets major underlying asset items follows buildings structures years machinery vehicles years tools furniture fixtures years land years lease payments recognized upon apportionment finance expenses repayments lease liabilities based interest method group recognize rightofuse assets lease liabilities leases intangible assets shortterm leases within months group recognizes total lease payments associated short term leases either straightline method another systematic basis lease term impairment property plant equipment intangible assets group assesses whether indication impairment end reporting period property plant equipment intangible assets including rightofuse assets applies hereinafter indication exists recoverable amount asset estimated possible estimate recoverable amount individual asset group estimates recoverable amount cashgenerating unit asset belongs cashgenerating unit smallest identifiable group assets generates cash inflows largely independent cash inflows assets groups assets intangible assets indefinite useful lives yet available use recoverable amounts estimated end fiscal year regardless whether indication impairment recoverable amount individual asset cashgenerating unit measured higher fair value less cost disposal value use value use calculated discounting estimated future cash flows present value using pretax discount rate reflects time value money risks specific asset corporate assets independently generate cash inflows indication impairment corporate assets recoverable amount cashgenerating unit corporate assets belong calculated impairment loss recognized profit loss carrying amount asset cashgenerating unit exceeds recoverable amount impairment loss recognized prior periods group assesses whether indication decrease disappearance impairment loss end reporting period indication reversal impairment loss recoverable amount asset cashgenerating unit estimated cases recoverable amount exceeds carrying amount asset cash generating unit impairment loss reversed lower recoverable amount carrying amount less depreciation amortization costs would determined impairment loss recognized assets held sale assets groups assets expected recovered continuous use sale classified non current assets disposal groups held sale quite likely sold within one year available immediate sale present condition management group committed sale case noncurrent assets neither depreciated amortized measured carrying amount fair value less cost sales whichever lower postemployment benefits group defined benefit plans defined contribution plans postemployment benefit plans employees group uses projected unit credit method determine present value defined benefit obligations related current service cost past service cost discount rate determined based market yields high quality corporate bonds end fiscal year consistent discount period set projected period expected date benefit payment fiscal year net defined benefit liabilities assets calculated deducting fair value plan assets present value defined benefit obligations defined benefit plan surplus defined benefit asset limited asset ceiling present value future economic benefits available form reductions future contributions plan cash refunds service costs net interest net defined benefit liabilities assets recognized profit loss remeasured amount defined benefit plan recognized comprehensive income occurs immediately transferred retained earnings contributions defined contribution retirement benefits recognized expenses employees rendered service provisions provisions recognized present legal constructive obligations result past events probable outflows resources embodying economic benefits required settle obligations reliable estimates made amount obligations amount recognized provisions best estimate taking account risks uncertainties expenditure required settle present obligations reporting date time value money material amount provision measured present value expenditures expected required settle obligation treasury shares treasury shares measured acquisition cost deducted equity gain loss recognized associated purchase sale retirement treasury shares company difference carrying amount consideration received sale recognized capital surplus sharebased payments equitysettled sharebased payment plan group adopted restricted stock remuneration plan accounted equitysettled share based payment restricted stock remuneration measured fair value grant date recognized expenses vesting periods grant date corresponding amounts increases equity fair value restricted stock remuneration measured reference fair value granted shares company ii cashsettled sharebased payment plan group granted equitylinked remuneration entitlements eligible personnel cashsettled sharebased payment plan cashsettled sharebased payment measured fair value payment amount recognized expenses vesting periods corresponding amounts increases liabilities group remeasures fair value liabilities end reporting period liabilities settled recognizes changes fair value profit loss revenue sales products sales products performance obligation judged satisfied revenue therefore recognized upon delivery products legal title physical possession significant risks rewards ownership products transferred customer upon delivery customer obtains control products products may sold rebate based upon achievement defined sales volume amount case transaction price recognized consideration promised contract customer less estimated rebates items rebates measured likely amount method based historical performance revenue recognized extent highly probable significant reversal occur specifically connection rebates medicaid medicare commercial managed care program us group estimates statutory contractual rebate payments related public healthcare system provided federal state governments contractual rebate payments medical institutions customers prepare possible refunds end fiscal year group estimates accrual amounts process identifying target products program applicable product prices estimated inventory pharmacies wholesalers time lag sales products payment rebates however estimates uncertain may differ actual amount incurred estimated amount rebate payments recorded current liabilities consolidated statement financial position majority consideration sales received within one year date delivery therefore promised amount consideration include significant financing component ii license royalty income license income includes upfront milestone payments group receives third party based license agreements development distribution right developing finished products license agreements contractual obligations fulfilled point time upfront payments recognized revenue development distribution rights granted milestone payments recognized revenue contractual milestones achieved contractual obligations fulfilled period time principle payments recorded contract liabilities recognized revenue period estimated contract term accordance measurement method progress towards satisfaction performance obligations related development cooperation determined contract income milestone payments license agreements recognized revenue point conditions met avoid future reversal revenues royalty income income calculated based sales counterparties license agreements recognized revenue later point either counterpartys revenue recognition satisfaction performance obligations license royalty income received primarily within one year time rights acquired based agreements therefore agreements include significant financing components government grants grant income measured fair value recognized reasonable assurance group comply conditions attached grants grants received grants revenue incurred recorded revenue fiscal year expenses occurred grants assets recorded revenue regularly useful life asset unearned grant income recorded liability finance income finance expenses finance income principally consists interest income dividend income gain fair value valuation foreign exchange gains interest income recognized using effective interest method dividend income recognized groups right receive dividend established finance expenses principally consist interest expenses loss fair value valuation foreign exchange losses income taxes income taxes consist current taxes deferred taxes taxes recognized profit loss except related business combinations items recognized directly equity comprehensive income current taxes calculated amount expected tax payment expected tax refund tax authorities amount taxes computed accordance tax rates tax laws effect substantially effect end fiscal year countries group conducts business activities earns taxable profits losses deferred taxes recognized temporary differences accounting carrying amounts assets liabilities reporting date amounts tax purposes unused tax losses unused tax credits deferred tax assets liabilities recorded following temporary differences temporary differences arising goodwill temporary differences arising initial recognition assets liabilities occur transactions affect neither accounting profit taxable profit tax purposes except business combinations cases taxable temporary differences associated investments subsidiaries associates timing reversal controlled highly probable temporary differences reversed foreseeable period cases deductible temporary differences associated investments subsidiaries associates highly probable temporary differences reversed extent foreseeable deferred tax liabilities recognized principle taxable temporary differences deferred tax assets recognized deductible temporary differences extent highly probable taxable profits available deductible temporary differences could utilized carrying amount deferred tax assets reviewed annually reduced amount deferred tax assets taxable profit sufficient use part deferred tax assets unlikely earned unrecognized deferred tax assets reassessed annually recognized extent highly probable deferred tax assets realizable future taxable profit company certain subsidiaries apply consolidated taxation system deferred tax assets liabilities calculated accordance tax rates tax laws expected applied period assets realized liabilities settled based tax rates tax laws effect substantially effect end fiscal year deferred tax assets liabilities offset group legally enforceable right offset current tax assets current tax liabilities related income taxes levied taxation authority taxable entity earnings per share basic earnings per share calculated dividing profit loss year attributable ordinary equity holders company weighted average number ordinary shares issued period adjusted number treasury shares diluted earnings per share calculated reflecting adjustment impact diluted shares dilutive effect significant accounting estimates judgments preparing ifrscompliant consolidated financial statements management required make judgments estimates assumptions may affect application accounting policies reported amounts assets liabilities income expenses actual results may differ estimates estimates underlying assumptions reviewed ongoing basis effects review accounting estimates recognized accounting period review conducted future accounting periods estimates judgments significant effects amounts recognized consolidated financial statements follows impairment intangible assets item note significant accounting policies note impairment assets fair value financial instruments notes financial instruments business combinations recoverability deferred tax assets note income taxes measurements defined benefit obligations note postemployment benefits estimation statutory contractual rebates related public healthcare system us item note significant accounting policies note liabilities changes circumstances occurring future pandemic covid uncertain risk could significantly affect reported amounts assets liabilities income expenses following fiscal year thereafter operating segments overview reportable segments groups reportable segments constituent units group separate financial information available subject periodic reviews board directors order make decisions allocation business resources evaluate business performances respective segments groups holding company company directs groups strategic planning monitors group operations provides various services group companies business activities conducted groups subsidiaries associates centering healthcare business group operates activities inside outside japan relating following four reportable segments pharmaceuticals nutraceuticals consumer products others businesses group defines reportable segments follows pharmaceuticals comprises manufacturing sales prescription drugs intravenous solutions nutraceuticals comprises manufacturing sales functional beverages overthecounter drugs nutritional supplements consumer products comprises manufacturing sales mineral water soft beverages food products others encompasses logistics warehousing manufacturing sales chemical products evaluation systems led displays spectroanalysis devices revenue performances reportable segment revenue performances group reportable segment follows segment profit based operating profit intersegment revenue transfers reflect reasonable prices intersegment transfers based market value fy fiscal year ended december millions yen reportable segment adjustments consolidated pharma nutra consumer others total ceuticals ceuticals products revenue revenue external customers intersegment revenue transfers total segment profit items depreciation amortization expenses share profit investments accounted using equity method impairment losses capital expenditures fy fiscal year ended december millions yen reportable segment adjustments consolidated pharma nutra consumer others total ceuticals ceuticals products revenue revenue external customers intersegment revenue transfers total segment profit items depreciation amortization expenses share profit loss investments accounted using equity method impairment losses capital expenditures details adjustments follows segment profit details adjustments segment profit follows millions yen fy fy fiscal year ended fiscal year ended december december intersegment eliminations unallocated expenses income total unallocated expenses incurred administrative departments headquarters company certain subsidiaries ii items depreciation amortization expenses impairment losses adjustments include depreciation amortization expenses impairment losses property plant equipment intangible assets corporate assets associated headquarters functions company certain subsidiaries iii capital expenditures adjustments include capital expenditures relating corporate assets associated headquarters research functions company certain subsidiaries capital expenditures represent amount increases property plant equipment goodwill intangible assets information products services revenue external customers major product service follows millions yen fy fy fiscal year ended fiscal year ended december december pharmaceuticals abilify maintena rexultirxulti samsca jinarcjynarque clinical nutrition nutraceuticals functional beverages etc functional foods etc supplements functional beverages etc consist pocari sweat tiovita drink oronamin c fibemini os body maint etc functional foods etc consist products nutrition sant sas group calorie mate products daiya foods inc etc supplements consist products pharmavite llc group equelle etc information geographical area revenue external customers millions yen fy fy fiscal year ended fiscal year ended december december japan north america europe others total revenue external customers classified based location customers amounts north america revenue us fy fy million million respectively noncurrent assets millions yen fy fy december december japan north america europe others total noncurrent assets classified based location assets noncurrent assets include investments accounted using equity method financial assets deferred tax assets noncurrent assets excluding longterm prepaid expenses goodwill included noncurrent assets classified based location investees amounts north america noncurrent assets us fy fy million million respectively information major customers information presented revenue transactions single external customer amounts groups revenue cash cash equivalents breakdown cash cash equivalents follows millions yen fy fy december december cash cash equivalents cash deposits banks deposit terms three months less shortterm investments original maturities three months less total cash cash equivalents trade receivables breakdown trade receivables follows millions yen fy fy december december notes accounts receivable trade accounts receivable allowance credit losses total amount assets pledged collateral borrowings included trade receivables million fy million fy inventories breakdown inventories follows millions yen fy fy december december merchandise finished goods workin process raw materials supplies total inventories scheduled sold months cost inventories recognized expenses million fy million fy amount assets pledged collateral borrowings included inventories million fy million fy amount writedowns inventories recognized expense follows millions yen fy fy fiscal year ended fiscal year ended december december amount writedowns financial assets breakdown financial assets follows millions yen fy fy december december financial assets measured amortized cost time deposits money trusts leasehold guarantee deposits bonds others financial assets measured fair value profit loss equity instruments derivatives financial assets measured fair value comprehensive income equity instruments total financial assets current financial assets noncurrent assets breakdown assets follows millions yen fy fy december december prepaid expenses net defined benefit assets others total total current assets current assets total noncurrent assets noncurrent assets assets held sale breakdown assets held sale liabilities directly associated assets held sale follows millions yen fy fy december december assets held sale property plant equipment buildings structures machinery vehicles land construction progress others total liabilities directly associated assets held sale lease liabilities others total major assets held sale fy idle assets pharmaceutical business consumer products business classified assets held sale decision sell assets assets held sale measured lower carrying amount fair value less costs sell fair value assets held sale expected sales price less cost disposal classified level hierarchy fair value hierarchy provided note financial instruments assets impairment losses million recorded fy included impairment losses consolidated statement income major assets held sale fy idle assets pharmaceutical business consumer products business classified assets held sale decision sell assets assets held sale measured lower carrying amount fair value less costs sell fair value assets held sale expected sales price less cost disposal classified level hierarchy fair value hierarchy provided note financial instruments assets impairment losses million recorded fy included impairment losses consolidated statement income sales scheduled completed following fiscal year property plant equipment changes costs accumulated depreciation accumulated impairment losses property plant equipment carrying amounts follows costs millions yen buildings machinery tools furniture construction land total structures vehicles fixtures progress balance january purchase disposal transfer transfer assets held sale foreign currency translation differences others balance december purchase business combination disposal transfer transfer assets held sale deconsolidation foreign currency translation differences others balance december accumulated depreciation accumulated impairment losses millions yen buildings machinery tools furniture construction land total structures vehicles fixtures progress balance january depreciation expenses impairment losses disposal transfer assets held sale foreign currency translation differences others balance december depreciation expenses impairment losses disposal transfer assets held sale deconsolidation foreign currency translation differences others balance december carrying amounts millions yen buildings machinery tools furniture construction land total structures vehicles fixtures progress balance january balance december balance december table amount related property plant equipment construction presented construction progress amounts related item property plant equipment include amount rightofuse assets please refer notes income expenses gain sales noncurrent assets loss sales noncurrent assets loss retirement noncurrent assets fy fy gain sales noncurrent assets loss sales noncurrent assets include gain loss sales assets held sale please refer note impairment assets details impairment losses please refer note commitments commitments related acquisition property plant equipment significant borrowing cost included costs property plant equipment assets pledged collateral carrying amounts assets pledged collateral borrowings etc included item property plant equipment follows millions yen buildings machinery tools furniture land total structures vehicles fixtures balance january balance december balance december rightofuse assets carrying amount rightofuse assets included item property plant equipment please refer note leases goodwill intangible assets changes costs accumulated amortization accumulated impairment losses goodwill intangible assets follows costs millions yen intangible assets trademarks goodwill inprocess distribution research software others total rights development others balance january purchase disposal transfer foreign currency translation differences others balance december purchase business combination disposal transfer transfer assets held sale deconsolidation foreign currency translation differences others balance december accumulated amortization accumulated impairment losses millions yen intangible assets trademarks goodwill inprocess distribution research software others total rights development others balance january amortization expenses impairment losses disposal foreign currency translation differences others balance december amortization expenses impairment losses disposal transfer assets held sale deconsolidation foreign currency translation differences others balance december carrying amounts millions yen intangible assets goodwill inprocess trademarks research distribution software others total development rights others balance january balance december balance december amortization expenses intangible assets included cost sales selling general administrative expenses research development expenses consolidated statements income please refer note impairment assets details impairment losses please refer note commitments commitments related acquisition intangible assets significant borrowing cost included costs intangible assets assets pledged collateral applicable individually significant intangible assets major intangible assets recorded consolidated statements financial position rights associated research development avp recognized line acquisition avanir pharmaceuticals inc executed carrying amounts rights associated research development avp million fy million fy impairment assets impairment losses calculating impairment losses group bases grouping assets smallest identifiable group assets generates largely independent cash inflows impairment losses recorded impairment losses consolidated statements income addition reversal impairment losses recorded income breakdown impairment losses reversals impairment losses segment follows millions yen fy fy fiscal year ended fiscal year ended december december pharmaceuticals nutraceuticals consumer products others corporate total pharmaceuticals impairment losses million pharmaceutical business recognized fy consist impairment losses property plant equipment million goodwill million intangible assets million impairment losses property plant equipment million principally reduction carrying amount assets construction progress recoverable amount value use following decision halt development certain drug agents impairment losses intangible assets million principally impairment loss million inprocess research development concerning guadecitabine development acute myeloid leukemia myelodysplastic syndromes ovarian cancer impairment loss million inprocess research development concerning vadadustat development anemia associated chronic kidney disease concerning guadecitabine carrying amount reduced recoverable amount zero value use following halting development indications based comprehensive review results phase iii trial acute myeloid leukemia myelodysplastic syndromes addition impairment loss vadadustat reduction carrying amount recoverable amount million value use based results phase iii trial nondialysis patients subsequent reevaluation business plan calculation value use discount rate based pretax weighted average cost capital used impairment losses million pharmaceutical business recognized fy consist impairment losses property plant equipment million intangible assets million assets held sale million impairment losses property plant equipment million principally reduction carrying amount machinery vehicles recoverable amount zero value use result certain machinery becoming idle due suspension operation impairment losses intangible assets million principally reduction carrying amount certain inprocess research development recoverable amount zero value use result reviewing probability success development due delay original development schedule impairment losses assets held sale million principally reduction carrying amount assets held sale fair value less costs sell due decision made sell certain businesses impairment test goodwill company considers cashgenerating units goodwill allocated principle cash generating units expected benefit synergies business combination breakdown carrying amount goodwill segment major cashgenerating unit follows millions yen fy fy december december pharmaceuticals prescription drugs clinical nutrition products nutraceuticals consumer products others total group tests major goodwill impairment fiscal period whenever indication impairment follows prescription drugs clinical nutrition products goodwill allocated prescription drugs clinical nutrition products principally recognized association acquisitions usbased avanir pharmaceuticals inc astex pharmaceuticals inc visterra inc others carrying amount million fy million recoverable amount impairment test determined based value use value use reflects past experience external information calculated discounting estimated amount cash flows based business plan next five years approved management present value estimated amount cash flows reflects probability obtaining sales approval regulatory authorities probability success sales forecasts market share launch pretax weighted average cost capital cashgenerating unit used discount rate fy beyond forecast period business plan considering future uncertainty amount cash flows assumed equal amount final fiscal year business plan subsequent growth rate deemed risk impairment may occur key assumptions used impairment test changed however value use adequately exceeds carrying amount cashgenerating unit even key assumptions used impairment test change provided change within reasonably predictable range considered unlikely value use fall carrying amount impairment test inprocess research development intangible assets yet available use inprocess research development tested impairment fiscal period whenever indication impairment recoverable amount impairment test determined based value use value use reflects past experience external information calculated discounting estimated amount cash flows based business plan approved management present value pretax weighted average cost capital cashgenerating unit used discount rate measurement value use reflects probability obtaining sales approval regulatory authorities probability success sales forecasts market share launch management considers assumptions used estimates appropriate however uncertainty healthcare market environment changes rapidly therefore assumed situation changes due delay halt development launches competing products calculation result value use could different inprocess research development fy principally rights related research development avp carrying amount million fy million discount rate fy investments accounted using equity method significant associates applicable individually insignificant associates carrying amount investments individually insignificant associates follows millions yen fy fy december december carrying amount investments accounted using equity method financial information individually insignificant associates follows amounts adjustment groups ownership ratio millions yen fy fy fiscal year ended fiscal year ended december december profit year comprehensive income comprehensive income year income taxes deferred taxes deferred tax assets deferred tax liabilities consolidated statements financial position follows millions yen fy fy december december deferred tax assets deferred tax liabilities net amount changes deferred tax assets deferred tax liabilities follows millions yen recognized recognized balance balance profit others december january comprehensive loss income inventories securities etc intangible assets postemployment benefits accrued expenses liabilities contract liabilities unused tax losses unused tax credits others total millions yen recognized recognized balance balance business profit others december january comprehensive combination loss income inventories securities etc intangible assets postemployment benefits accrued expenses liabilities contract liabilities unused tax losses unused tax credits others total deferred tax assets recognized deductible temporary differences unused tax losses unused tax credits extent highly probable taxable profits available could utilized assessment recoverability deferred tax assets reversal deferred tax liabilities expected future taxable profit tax planning taken account carrying amount reviewed fiscal year based level taxable profit past estimated future taxable profit period deferred tax assets deductible group considers probable deferred tax assets recognized december recovered future taxable profit tax planning estimated based groups business plan different result forecasts revenue business plan occurs may significant impact amount deferred tax assets consolidated financial statements following fiscal year unrecognized deferred tax assets deductible temporary differences unused tax losses unused tax credits deferred tax asset recognized follows millions yen fy fy december december deductible temporary differences unused tax losses unused tax credits total deferred tax assets items recognized low probability temporary differences reversed foreseeable future highly probable future taxable income necessary group utilize benefits arises deductible temporary differences expire current tax law expiration unused tax losses company subsidiaries follows millions yen fy fy december december due within one year due one year five years due five years total taxable temporary differences deferred tax liabilities recognized unrecognized deferred tax liabilities follows cases company control timing reversal temporary differences highly probable temporary differences reversed foreseeable period deferred tax liabilities associated temporary differences recognized millions yen fy fy december december temporary differences related investments subsidiaries associates deferred tax liabilities recognized company decided pay dividend foreseeable future income tax expenses effective tax rates fy fy japan tax amount tax jurisdictions calculated using general tax rate jurisdiction breakdown current tax expenses deferred tax expenses follows millions yen fy fy fiscal year ended fiscal year ended december december current tax expenses current income taxes income taxes prior periods total current tax expenses deferred tax expenses origination reversal temporary differences etc changes unrecognized deferred tax assets total deferred tax expenses total income tax expenses reconciliation effective statutory tax rate actual tax rate fiscal year follows actual tax rate represents ratio income tax expenses profit tax fy fy fiscal year ended fiscal year ended december december effective statutory tax rate special deduction research development expenses entertainment expenses deductible taxable income pharma fees deductible taxable income share profit investments accounted using equity method changes unrecognized deferred tax assets difference tax rate applied subsidiaries others actual tax rate trade payables breakdown trade payables follows millions yen fy fy december december notes accounts payable trade accounts payable others total bonds borrowings breakdown bonds borrowings follows millions yen fy fy average december december year maturity interest rate secured shortterm borrowings current portion longterm borrowings longterm borrowings excluding current portion unsecured shortterm borrowings current portion longterm borrowings longterm borrowings excluding current portion bonds total bonds borrowings current bonds borrowings noncurrent average interest rate represents weighted average interest rate balance borrowings etc end year breakdown longterm borrowings repayment date fair value please refer note financial instruments summary terms conditions bonds issued follows fy fy interest date december december company name name rate collateral maturity issuance millions yen millions yen st otsuka holdings march march unsecured none co ltd bonds nd otsuka holdings march march unsecured none co ltd bonds rd otsuka holdings march march unsecured none co ltd bonds total figures brackets indicate amounts redeemed within one year financial liabilities breakdown financial liabilities follows millions yen fy fy december december financial liabilities measured amortized cost others financial liabilities measured fair value profit loss derivative liabilities contingent consideration total financial liabilities current financial liabilities noncurrent leases property plant equipment consists property plant equipment owned company right ofuse assets meet definition investment property rightofuse assets included property plant equipment consolidated statements financial position millions yen fy fy december december property plant equipment owned company rightofuse assets total please refer note property plant equipment changes costs accumulated depreciation accumulated impairment losses property plant equipment carrying amounts rightofuse assets information leases group contracted lessee follows millions yen buildings machinery tools furniture carrying amount land total structures vehicles fixtures balance january purchase depreciation expenses others balance december purchase depreciation expenses others balance december buildings structures buildings structures principally consist leases plants office buildings warehouses machinery vehicles machinery vehicles principally consist leases automobiles tools furniture fixtures tools furniture fixtures principally consist leases vending machines equipment land land principally consist leases land factories details estimated useful life provided note significant accounting policies leases lease liabilities maturity analysis lease liabilities group contractual undiscounted cash flows follows millions yen fy fy december december due within one year due one year two years due two years three years due three years four years due four years five years due five years contractual cash flows balance lease liabilities end year recognized consolidated statements financial position current liabilities noncurrent liabilities amount recognized profit loss millions yen fy fy fiscal year ended fiscal year ended december december interest expense lease liabilities expense relating shortterm leases amount recognized statements cash flows millions yen fy fy fiscal year ended fiscal year ended december december total cash outflow leases liabilities breakdown liabilities follows millions yen fy fy december december accrued expenses deposits received employees bonuses others total total current liabilities current liabilities total noncurrent liabilities noncurrent liabilities stated item note significant accounting policies accrued expenses include estimated amount rebate payments medicaid medicare commercial managed care program us million fy million provisions breakdown provisions follows millions yen fy fy december december provision asset retirement obligations provision loss contracts provisions total current liabilities noncurrent liabilities breakdown changes provisions follows fy fiscal year ended december millions yen provision asset retirement total obligations balance january increase year reversal discounts due passage time decrease year utilization decrease year reversal foreign currency translation differences others balance december fy fiscal year ended december millions yen provision asset provision loss provisions total retirement obligations contracts balance january increase year reversal discounts due passage time decrease year utilization decrease year reversal foreign currency translation differences others balance december details provisions follows provision asset retirement obligations group records provision asset retirement obligations estimated amount costs removal harmful substances related noncurrent assets estimated amount restoration costs rented offices others group obligations restore site original condition end lease contract group expects timing economic resources flow principally one year passed end fiscal year provision loss contracts provisions recorded onerous contracts concerning copromotion agreements related prescription drugs group expects timing economic resources flow principally within one year end fiscal year postemployment benefits group adopted defined benefit plans defined contribution plans postemployment benefit plans major domestic subsidiaries contributory funded defined benefit corporate pension plan lumpsum retirement payments plan defined benefit plans defined contribution pension plans defined contribution plans certain foreign subsidiaries contributory funded unfunded defined benefit plans defined contribution plans combination among defined benefit plans major plan defined benefit plan japan accounts approximately total defined benefit obligations current fiscal year domestic subsidiaries abolished early retirement plans postemployment benefit pensions lumpsum payments accounting policy defined benefit plans please refer note significant accounting policies postemployment benefits defined benefit obligations calculated using actuarial technique actuarial assumptions include estimate discount rate assumptions may affected uncertain future economic conditions changes social situations factors different result assumptions occurs may significant impact amounts net defined benefit liabilities net defined benefit assets included noncurrent assets consolidated financial statements following fiscal year defined benefit plans benefits defined benefit plans company major domestic subsidiaries amount retirement benefit payments calculated based service years salaries service period position factors period validity retiring employee equals certain period benefits paid lumpsum payment pension option employee upon retirement etc employees additional retirement benefits qualify benefits defined benefit plans may paid defined benefit corporate pension plans managed otsuka pharmaceuticals corporate pension fund directors pension fund pension plan management institution required laws regulations behave way gives utmost priority interest plan participants former participants assume responsibility managing plan assets prescribed policy although defined benefit retirement benefit plans exposed general investment risk interest rate risk others considered exposure risks significant amounts recognized consolidated statements financial position follows millions yen fy fy december december present value defined benefit obligations fair value plan assets funding position effect asset ceiling net amount defined benefit obligations plan assets amounts consolidated statements financial position net defined benefit liabilities net defined benefit assets noncurrent assets net defined benefit liabilities assets recognized consolidated statements financial position changes present value defined benefit obligations follows millions yen fy fy fiscal year ended fiscal year ended december december balance defined benefit obligations beginning year current service cost interest cost remeasurement difference assumption actual amount retirement benefit obligations actuarial gains losses arising changes demographic assumptions actuarial gains losses arising changes financial assumptions retirement benefits paid curtailmentsettlement foreign currency translation differences others balance defined benefit obligations end year changes fair value plan assets follows millions yen fy fy fiscal year ended fiscal year ended december december balance fair value plan assets beginning year interest income plan assets remeasurement return plan assets excluding interest income contributions employer retirement benefits paid curtailmentsettlement foreign currency translation differences others balance fair value plan assets end year group plans pay contributions million fy management policy plan assets fund management policy major plans group aims secure stable returns medium long term ensure payment defined benefit obligations future specifically assets managed setting target rate return asset mix investment asset within range acceptable risk defined annually maintaining mix group conducts review asset mix necessary taking account financial conditions defined benefit pension plans investment environment management asset implemented group seeks efficiency investment aspect continuous monitoring attention risk diversification associated asset managers fair value plan assets follows millions yen fy fy december december assets market assets without market assets market assets without market prices active markets prices active markets prices active markets prices active markets cash cash equivalents shares bonds others total companys investment policy defined benefit plans takes consideration various factors allowable limit deductible expenses tax laws funding status plan assets actuarial calculations changes effect asset ceiling follows millions yen fy fy fiscal year ended fiscal year ended december december balance effect asset ceiling beginning year interest income remeasurement effect limiting net defined benefit asset asset ceiling balance effect asset ceiling end year economic resource available future contributions reduced refunded consequently unrecognized surplus arisen pension plans group principal actuarial assumptions end reporting period follows fy fy december december discount rate following table represents sensitivity analysis significant actuarial assumptions sensitivity analysis shows impact increase decrease assumptions used actuarial calculation present value defined benefit obligations analysis based assumption variables constant analysis fy made using fundamentals fy millions yen fy fy fiscal year ended fiscal year ended december december increase discount rate decrease discount rate weighted average duration defined benefit obligations december years years respectively defined contribution plans amounts recognized expenses association defined contribution plans million fy million fy figures include amounts recognized expenses association public plans equity equity items share capital capital surplus changes number authorized shares total number issued shares balance share capital etc follows number authorized total number issued shares shares share capital capital surplus ordinary shares ordinary shares millions yen millions yen par value par value balance january shares shares changes year balance december shares shares changes year balance december shares shares treasury shares changes number balance treasury shares follows number shares amount shares millions yen balance january increase due request buyback shares less one share unit acquisition without contribution ordinary shares allotted restricted stock remuneration decrease due disposal restricted stock remuneration balance december increase due request buyback shares less one share unit acquisition without contribution ordinary shares allotted restricted stock remuneration decrease due disposal restricted stock remuneration balance december company adopted restricted stock remuneration plan appropriates treasury shares grant shares plan contractual terms conditions amount others plan provided note sharebased payments furthermore circumstances companys shares granted may acquired company without contribution capital surplus companies act japan hereinafter companies act least contribution share issue shall credited share capital remainder shall credited additional paidin capital included capital surplus addition companies act additional paidin capital transferred share capital upon approval shareholders meeting retained earnings companies act provides dividends shall appropriated additional paidin capital legal reserve aggregate amount additional paidin capital legal reserve equals share capital legal reserve may used eliminate reduce deficit may also reversed upon approval shareholders meeting details purpose components equity remeasurements defined benefit plans remeasurements defined benefit plans represent actuarial difference defined benefit obligation return plan assets excluding amount included interest income changes effect asset ceiling excluding amount included interest income actuarial difference represents adjustment based past experience defined benefit obligation difference actuarial assumptions beginning year actual results effect changes actuarial assumptions items recognized comprehensive income occurred immediately transferred components equity retained earnings ii financial assets measured fair value comprehensive income financial assets measured fair value comprehensive income represent valuation difference fair value financial assets measured fair value comprehensive income iii exchange differences translation foreign operations exchange differences translation foreign operations represent translation difference incurred consolidating financial statements foreign operations prepared using foreign currencies iv cash flow hedges group uses derivatives hedge risk fluctuation future cash flows cash flow hedges represent effective portion changes fair value derivative transactions designated cash flow hedges dividends dividends paid follows fy fiscal year ended december total amount dividends per share resolution dividends record date effective date yen millions yen meeting board directors held december march february meeting board directors held august june september fy fiscal year ended december total amount dividends per share resolution dividends record date effective date yen millions yen meeting board directors held december march february meeting board directors held august june september dividends whose effective date falls following fiscal year follows fy fiscal year ended december total amount dividends per share resolution dividends record date effective date yen millions yen meeting board directors held december march february fy fiscal year ended december total amount dividends per share resolution dividends record date effective date yen millions yen meeting board directors held december march february revenue disaggregation revenue group disaggregates revenue type goods services geographical area relationship disaggregated revenue reportable segments follows fy fiscal year ended december millions yen reportable segment pharma consumer nutraceuticals others total ceuticals products type goods services sales products license royalty income others total geographical area japan north america europe others total revenue classified based location customers fy fiscal year ended december millions yen reportable segment pharma consumer nutraceuticals others total ceuticals products type goods services sales products license royalty income others total geographical area japan north america europe others total revenue classified based location customers contract balance breakdown receivables contract liabilities contracts customers follows millions yen fy fy january december december receivables contracts customers notes accounts receivable trade allowance credit losses contract liabilities current liabilities contract liabilities noncurrent liabilities opening balance contract liabilities amount revenue recognized million fy million fy amount revenue recognized performance obligations satisfied partially satisfied past period million fy million fy major revenue license royalty income timing satisfaction performance obligations contract liabilities mainly arise certain license agreements entered group third party development distribution rights others products development addition contract liabilities include advances received customers relation sale products total amount transaction price allocated remaining performance obligations timing revenue expected recognized follows millions yen fy fy fiscal year ended fiscal year ended december december due within one year due one year two years due two years three years due three years four years due five years total breakdown expenses nature major breakdown expenses included cost sales selling general administrative expenses research development expenses nature follows millions yen fy fy fiscal year ended fiscal year ended december december personnel expenses sales promotion expenses depreciation amortization expenses income breakdown income follows millions yen fy fy fiscal year ended fiscal year ended december december grant income rent received gain sales noncurrent assets change fair value contingent considerations gain change equity others total income amount includes gain sales assets held sale fair value changes contingent considerations attributable time value recognized finance expenses attributable time value recognized either income expenses fair value changes contingent considerations recorded income relates acquisition neurovance inc expenses breakdown expenses follows millions yen fy fy fiscal year ended fiscal year ended december december loss sales noncurrent assets loss retirement noncurrent assets change fair value contingent considerations others total expenses fair value changes contingent considerations attributable time value recognized finance expenses attributable time value recognized either income expenses fair value changes contingent considerations recorded expenses relates acquisition neurovance inc finance income finance expenses breakdown finance income finance expenses follows millions yen fy fy fiscal year ended fiscal year ended december december finance income interest income financial assets measured amortized cost dividend income financial assets measured fair value comprehensive income gain fair value valuation financial assets liabilities measured fair value profit loss foreign exchange gains others total finance income finance expenses interest expenses financial liabilities measured amortized cost lease liabilities loss fair value valuation financial assets liabilities measured fair value profit loss foreign exchange losses others total finance expenses comprehensive income reclassification adjustments income taxes separate component comprehensive income follows millions yen fy fy fiscal year ended fiscal year ended december december items reclassified profit loss remeasurements defined benefit plans amount arising year income taxes income taxes remeasurements defined benefit plans financial assets measured fair value comprehensive income amount arising year income taxes income taxes financial assets measured fair value comprehensive income share comprehensive income investments accounted using equity method amount arising year share comprehensive income investments accounted using equity method subtotal items may reclassified profit loss exchange differences translation foreign operations amount arising year reclassification adjustments income taxes exchange differences translation foreign operations cash flow hedges amount arising year reclassification adjustments income taxes income taxes cash flow hedges share comprehensive income investments accounted using equity method amount arising year reclassification adjustments share comprehensive income investments accounted using equity method subtotal total comprehensive income earnings per share basis calculating basic earnings per share fy fy fiscal year ended fiscal year ended december december profit year attributable owners company millions yen profit year attributable ordinary equity holders company millions yen profit year used calculation basic earnings per share millions yen weighted average number ordinary shares thousands shares basic earnings per share yen basis calculating diluted earnings per share fy fy fiscal year ended fiscal year ended december december profit year used calculation basic earnings per share millions yen adjustments profit year millions yen profit year used calculation diluted earnings per share millions yen weighted average number ordinary shares thousands shares increase ordinary shares share acquisition rights thousands shares weighted average number diluted ordinary shares thousands shares diluted earnings per share yen sharebased payments group introduced restricted stock remuneration plan directors company excluding outside directors certain directors subsidiaries aiming granting incentives achieve mediumterm management plan sustainably improve medium longterm performance corporate value company share value shareholders addition group granted equitylinked remuneration entitlements cashsettled sharebased payment plan officers employees certain consolidated subsidiaries group grants entitlements employees rank time grant makes payment cash taking account level achievement performance targets share price end period cycle cycle oneyear period cycle threeyear period restricted stock remuneration plan details restricted stock remuneration plan follows date grant may april april number shares granted shares shares shares fair value date grant settlement method equitysettled equitysettled equitysettled may june april april transfer restriction period june june persons granted directors company excluding outside directors certain directors subsidiaries hereinafter referred eligible directors company entered eligible director restricted stock allocation agreement contains provisions eligible directors shall transfer attach security interest make dispositions companys ordinary shares allotted hereinafter referred allotted shares company acquires allotted shares cost upon occurrence specified events company shall remove transfer restriction allotted shares condition eligible director continuously holds position director company director subsidiary eligible director director subsidiary transfer restriction period targets set company advance light consolidated revenue operating profit metrics achieved determined person eligible allotment retires due expiration term office reasonable cause time release transfer restriction number shares released transfer restriction reasonably adjusted necessary method measuring fair value calculated based closing price shares company first section tokyo stock exchange business day prior date resolution board directors sharebased remuneration expenses breakdown sharebased remuneration expenses follows millions yen fy fy fiscal year ended fiscal year ended december december equitysettled cashsettled total carrying amount liabilities arising sharebased payment transactions million fy million fy financial instruments capital management groups basic policy capital management improve capital efficiency ensure financial soundness order achieve sustainable growth enhance corporate value medium long term group conducts monitoring financial indicators procedure capital management group monitors return equity attributable owners company capital efficiency ratio equity attributable owners company total assets financial soundness timely manner group subject material capital restrictions classification financial instruments breakdown financial assets financial liabilities category follows millions yen fy fy december december financial assets financial assets measured amortized cost cash cash equivalents trade receivables financial assets financial assets measured fair value profit loss financial assets financial assets measured fair value comprehensive income financial assets total financial assets financial liabilities financial liabilities measured amortized cost trade payables bonds borrowings financial liabilities financial liabilities measured fair value profit loss financial liabilities total financial liabilities financial risk management group exposed financial risks market risk credit risk liquidity risk course operating activities conducts risk management accordance policy mitigate financial risks group uses derivative transactions avoid foreign currency risk interest rate risk accordance policy carry speculative transactions market risk management groups activities mainly exposed risks changes economic circumstances financial market circumstances specifically risks changes financial market circumstances include foreign currency risk interest rate risk risk fluctuations equity instrument prices foreign currency risks foreign currency risk management group engages business globally fluctuations exchange rates us dollar euro principally affect operating results regard settlement receivables payables arising ongoing operating activities groups policy balance foreign exchange receipts payments much possible three major currencies namely us dollar euro japanese yen addition group established management rules derivative transactions limits derivative transactions including forward foreign exchange contracts purpose hedging risks information derivative transactions conducted group provided fair value financial instruments ii fair value derivatives ii foreign exchange sensitivity analysis group principally exposed foreign currency risks us dollar euro following table shows sensitivity analysis case yens value increases us dollar euro fiscal year making calculations group assumed changes currencies used impact translation functional currencydenominated financial instruments assets liabilities income expenses foreign operations yen included based assumption variable factors balances interest rate constant millions yen fy fy fiscal year ended fiscal year ended december december us dollar impact profit tax impact comprehensive income application tax effects euro impact profit tax impact comprehensive income application tax effects figures parentheses represent negative effects profit loss equity group case yens value increases currency figures show effects currency translation groups consolidated financial statements direct positive negative effects cash flows business management groups exposures foreign exchange fluctuation risks us dollar euro significant interest rate risk interest rate risk management group exposed various interest rate risks business activities fluctuations interest rates associated borrowings especially affect operating results however effect interest rate fluctuations borrowing costs offset income arising assets affected interest rate fluctuations group monitors fluctuations interest rates arising assets liabilities manages interest rate risks refinancing means interest rates drastically fluctuate ii interest rate sensitivity analysis impact increase interest rates fiscal year profit tax group follows analysis calculation made multiplying balances financial instruments variable interest rates held group end fiscal year assuming variables constant millions yen fy fy fiscal year ended fiscal year ended december december impact profit tax risk fluctuations equity instrument prices risk management price fluctuations equity instruments group exposed risk stock price fluctuations equity instruments group equity instruments held shortterm trading owns equity instruments execute business strategies smoothly regard equity instruments group regularly assesses fair value monitors issuers financial conditions ii price sensitivity analysis equity instruments listed shares held group following table shows impact decrease share price comprehensive income application tax effects group assuming variables constant millions yen fy fy fiscal year ended fiscal year ended december december impact comprehensive income application tax effects equity instruments measured fair value comprehensive income fair value equity instruments measured fair value comprehensive income dividend income follows millions yen fy fy fiscal year ended fiscal year ended december december fair value dividend income fair value dividend income listed unlisted total fair value major financial assets follows group classifies investments held purpose reinforcing sales foundations financial assets measured fair value comprehensive income fy december millions yen name amount listed daiichi sankyo company limited eiken chemical co ltd compass pathways plc vv food beverage co ltd awa bank ltd others unlisted electrical equipment pharmaceuticals others total names major unlisted shares nichia corporation electrical equipment somalogic inc pharmaceuticals pact pharma inc pharmaceuticals fy december millions yen name amount listed daiichi sankyo company limited vv food beverage co ltd eiken chemical co ltd bml inc awa bank ltd others unlisted electrical equipment pharmaceuticals others total names major unlisted shares nichia corporation electrical equipment dren bio inc pharmaceuticals pact pharma inc pharmaceuticals group sells equity instruments measured fair value comprehensive income using results obtained verifying reasonableness holding factors fair value time sale cumulative gains losses pretax follows millions yen fy fy fiscal year ended december fiscal year ended december fair value time sale cumulative gains losses fair value time sale cumulative gains losses item transferred comprehensive income retained earnings time sale amounts net tax transferred fy fy million million respectively fy dividend income financial assets measured fair value comprehensive income sold derecognized million dividend income fy credit risk management credit risk risk causes financial loss group counterparty financial asset held group goes default contractual obligations according credit management policy groups sales department accounting finance department regularly monitor credit status counterparty claims trade receivables manage due dates balances strive early identification mitigation concerns collections due deterioration financial position counterparty factors full partial collection trade receivables considered impossible extremely difficult deemed default group recognizes little credit risk use derivatives since group deals financial institutions high credit ratings mitigate credit risk group credit risk significantly concentrated specific counterparty group counterparty belongs allowance credit losses changes allowance credit losses follows fy fiscal year ended december millions yen lifetime expected credit losses financial assets financial assets total credit risk increased always measured significantly since initial amount equal lifetime recognition expected credit losses balance january increase year decrease year utilization decrease year reversal others balance december fy fiscal year ended december millions yen lifetime expected credit losses financial assets financial assets total credit risk increased always measured significantly since initial amount equal lifetime recognition expected credit losses balance january increase year decrease year utilization decrease year reversal others balance december exposure credit risk financial assets carrying amounts presented consolidated statement financial position represent groups maximum exposure credit risk financial assets liquidity risk management group manages liquidity risk accounting finance departments prepare update cash flow management plans maintaining constant level liquidity balance financial liabilities liability guarantee including derivative financial instruments maturity follows details lease liabilities provided note leases millions yen due due due due due fy carrying contractual due within one year two years three years four years five december amount cash flows one year two five years years three years four years years nonderivative financial liabilities trade payables borrowings bonds contingent consideration others total derivative financial liabilities forward exchange contracts others interest rate swaps currency swaps total millions yen due due due due due fy carrying contractual due within one year two years three years four years five december amount cash flows one year two five years years three years four years years nonderivative financial liabilities trade payables borrowings bonds contingent consideration others total derivative financial liabilities forward exchange contracts others interest rate swaps total fair value financial instruments details fair value financial instruments follows financial instruments settled short term carrying amount approximates fair value information fair value financial instruments omitted fair value hierarchy fair value hierarchy classifies inputs follows level observable inputs quoted market prices identical assets liabilities active markets level inputs level observable inputs asset liability either directly indirectly level unobservable inputs asset liability transfers fair value hierarchy levels recognized date event condition prompting transfer occurred financial instruments measured amortized cost millions yen fair value fy carrying amount december level level level total financial assets securities total financial liabilities borrowings bonds total millions yen fair value fy carrying amount december level level level total financial assets securities total financial liabilities borrowings bonds total fair value calculation methods follows securities fair value securities calculated based quoted price securities exchange borrowings fair value borrowings floating interest rates reflects market interest rates short term carrying amount approximates fair value fair value borrowings fixed interest rates calculated method future cash flows discounted using interest rate approximates funds borrowed terms conditions remaining borrowing period bonds fair value bonds calculated based observable price market ii fair value derivatives millions yen fy derivatives designated cash flow hedges total december hedges forward exchange contracts others interest rate swaps currency swaps total millions yen fy derivatives designated cash flow hedges total december hedges forward exchange contracts others interest rate swaps currency swaps call options total fair value calculation methods follows forward exchange contracts others fair value forward exchange contracts others calculated based market price forward exchange contracts others entered similar terms conditions interest rate swaps interest rate swaps used purpose reducing interest borne borrowings fair value calculated based present value derived discounting future cash flows interest rate reflecting period maturity date credit risk currency swaps currency swaps used purpose reducing foreign currency risks currencies borrowings fair value calculated based present value derived discounting future cash flows interest rate reflecting period maturity date credit risk call options fair value call options calculated based blackscholes model iii financial instruments measured fair value millions yen fy level level level total december financial assets financial assets measured fair value comprehensive income equity instruments financial assets measured fair value profit loss equity instruments total financial liabilities financial liabilities measured fair value profit loss derivatives contingent consideration total millions yen fy level level level total december financial assets financial assets measured fair value comprehensive income equity instruments financial assets measured fair value profit loss equity instruments derivatives total financial liabilities financial liabilities measured fair value profit loss derivatives contingent consideration total fy fy significant transfer level transfer level level due listing shares held please refer v reconciliation financial instruments classified level opening balances closing balances transfer iv valuation techniques inputs financial instruments classified level level valuation techniques inputs equity instruments fair value equity instruments measured using valuation technique appropriate characteristics instrument comparable company analysis method option pricing method measurement input information including stock price index comparable companies discount rate according risk instrument price conversion preference shares held group ordinary shares taken account derivatives information provided note financial instruments fair value financial instruments ii fair value derivatives contingent consideration contingent considerations classified level liabilities recognized result recognizing part considerations contingent considerations acquisition shares shares neurovance inc shares recor medical inc valuation techniques inputs fair value provided note business combinations b valuation processes fair value level financial instruments measured based internal regulations group adopted appropriate valuation techniques inputs reflect risks characteristics nature financial instruments subject valuation v reconciliation financial instruments classified level opening balances closing balances fair value measurement end year fy millions yen fiscal year ended december financial assets financial liabilities balance beginning year gains losses recorded profit loss recorded comprehensive income purchase issuance transfer level due listing others balance end year unrealized gains losses included profit loss assets liabilities held end year fair value measurement end year fy millions yen fiscal year ended december financial assets financial liabilities balance beginning year gains losses recorded profit loss recorded comprehensive income purchase issuance increase business combinations sales settlements transfer level due listing others balance end year unrealized gains losses included profit loss assets liabilities held end year gains losses included profit loss relate financial assets financial liabilities measured fair value profit loss reporting date gains losses included income finance income finance expenses consolidated statements income gains losses included comprehensive income mainly relate financial assets measured fair value comprehensive income reporting date gains losses included financial assets measured fair value comprehensive income exchange differences translation foreign operations consolidated statements comprehensive income hedge accounting group utilizes derivatives forward exchange contracts others hedge foreign currency risk associated forecast transactions denominated foreign currencies effect hedge accounting consolidated statements financial position insignificant descriptions omitted subsidiaries associates significant subsidiaries associates company provided overview company overview affiliated entities japanese fy significant changes major subsidiaries associates company related parties related party transactions outstanding balances transactions company consolidated subsidiaries companys related parties consolidated subsidiaries eliminated consolidation disclosed notes significant transaction volume balances receivables payables group related parties remuneration key management personnel remuneration key management personnel group follows millions yen fy fy fiscal year ended fiscal year ended december december fixed remuneration bonuses postemployment benefits sharebased payment total remuneration key management personnel business combinations significant business combinations fy fiscal year ended december significant business combinations fy fiscal year ended december significant business combinations contingent consideration contingent considerations recorded result business combinations involving neurovance inc recor medical inc etc contingent considerations acquisition neurovance inc consist milestones paid based progress development centanafadine compound development treatment adhd obtained group acquired neurovance inc march ones paid based revenue launch centanafadine maximum potential amounts milestones usd million usd million respectively contingent considerations acquisition recor medical inc milestones paid based progress development ultrasound renal denervation device obtained group acquisition june maximum potential amount milestones usd million fair value contingent considerations estimated based probabilityweighted present value potential amount paid counterparty level contingent considerations fair value hierarchy classified level fair value changes contingent considerations attributable time value recognized finance expenses attributable time value recognized either income expenses details fair value hierarchy provided note financial instruments changes fair value contingent considerations follows millions yen amount balance january changes fair value foreign currency translation adjustment balance december business combination changes fair value foreign currency translation adjustment balance december reconciliation liabilities arising financing activities reconciliation liabilities classified cash flows financing activities follows fy fiscal year ended december millions yen changes due noncash transactions balance balance december cash flow exchange december leases transfer rate others fluctuations current liabilities bonds borrowings lease liabilities financial liabilities total noncurrent liabilities bonds borrowings lease liabilities total fy fiscal year ended december millions yen changes due noncash transactions balance balance cash business exchange december flow december combination leases transfer rate others others fluctuations current liabilities bonds borrowings lease liabilities financial liabilities total noncurrent liabilities bonds borrowings lease liabilities total commitments commitments related expenditures reporting date follows millions yen fy fy december december acquisition property plant equipment acquisition intangible assets others commitments related acquisition intangible assets group entered license agreements development distribution rights products development finished products third parties group may pay certain amount money milestones related development sales targets specified agreements achieved represents maximum amount paid milestones achieved may different amount actually paid risk adjustment discount made amount subsequent events applicable others quarterly information fy cumulative period first three months first six months first nine months full year revenue millions yen profit tax millions yen profit attributable owners millions yen company basic earnings per share yen accounting period first quarter second quarter third quarter fourth quarter basic earnings loss per share yen ii litigation etc applicable iii events reporting date applicable